期刊文献+

奥沙利铂联合亚叶酸钙和替加氟时辰化疗治疗晚期胃肠癌的临床研究 被引量:4

Chronomodulated Chemotherapy of Oxaliplatin Combined with Calcium Folinate and Tegafur for Advanced Gastrointestinal Cancer
下载PDF
导出
摘要 目的比较奥沙利铂联合亚叶酸钙和替加氟时辰化疗方案与常规化疗方案治疗晚期胃肠癌的近期疗效和不良反应。方法63例晚期胃肠癌患者随机分为时辰化疗组(给予奥沙利铂、亚叶酸钙、替加氟栓)31例与常规化疗组(给予奥沙利铂、亚叶酸钙、氟尿嘧啶)32例,21d为1个周期,2个周期后评定2组的近期疗效和不良反应。结果时辰化疗组与常规化疗组的有效率分别为77·4%、43·8%(P<0·05),KPS评分显效率分别为87·1%、50·0%(P<0·05),不良反应发生率分别为13·7%、29·8%(P<0·05)。结论奥沙利铂联合亚叶酸钙和替加氟的时辰化疗方案有效率高,不良反应少。 OBJECTIVE: To evaluate and compare the efficacy and safety between the chronomodulated chemotherapy of oxaliplatin combined with calcium folinate and tegafur and the normal chemotherapy in the treatment of advanced gastroin testinal cancer.METHODS:A total of 63 patients with advanced gastrointestinal cancer were randomly divided into two groups: 31 in ehronomodulated chemotherapy regimen group were assigned to receive oxaliplatin in combination with calcium foilhate and tegafur, and another 32 in normal chemotherapy regimen group to receive oxaliplatin combined with calcium folinate and fluorouradl. 2 courses of treatment later(21 days/course of treatment) the shortterm effects and the adverse drug reae tions(ADRs) of the 2 groups were evaluated.RESULTS: The effective ratcs of the ehronomodulated chemotherapy group and the normal group were 77.4% and 43.8% (P〈0.05), respectively; effective rates in KPS scale were 87.1% and 50.0% (P〈 0.05) ,respectively;and percentages of ADRs were 13.7% and 29.8%(P〈0.05),respectively.CONCLUSION:The ehronomodulated chemotherapy of oxaliplatin combined with calcium folinate and tegafur is of high effective rates yet of low percentages of ADRs.
出处 《中国药房》 CAS CSCD 北大核心 2006年第22期1726-1728,共3页 China Pharmacy
关键词 胃肠肿瘤 奥沙利铂 替加氟 亚叶酸钙 氟尿嘧啶 时辰化疗 Gastrointestinal tumor Oxaliplatin Tegafur Calcium folinate Fluorouracil Chronomodulated chemotherapy
  • 相关文献

参考文献11

二级参考文献63

共引文献98

同被引文献62

  • 1王京芬.时辰化疗治疗非小细胞肺癌的临床观察[J].肿瘤防治杂志,2004,11(11):1192-1193. 被引量:9
  • 2瞿广桥,杨继洲.F/LVO方案时辰化疗治疗ⅢA期胃癌的临床观察[J].实用癌症杂志,2004,19(6):615-616. 被引量:6
  • 3张思奋,罗湛滨,吴文江,何晶,范小华.大肠癌术后时辰化疗联合中医时间医学治疗的临床研究[J].世界华人消化杂志,2005,13(14):1790-1791. 被引量:14
  • 4隋振忠,盛延兴,李学章,郑芳霞,于震.时辰化疗联合放疗治疗晚期贲门癌[J].现代肿瘤医学,2007,15(1):55-56. 被引量:7
  • 5Zeng ZL, Sun J, Guo L, et al. Circadian rhythm in dihydropyrimidine dehydrogenase activity and reduced glutathione content in peripheral blood of nasopharyngeal carcinoma patients [J]. Chronobio! Int, 2005, 22(4):741- 754.
  • 6Balmforth A J, Grant P3, Scott EM, et al. Inter-subject differences in constitutive expression levels of the clock gene in man. [J]. Diab Vasc Dis Res, 2007, 4(1): 39-43.
  • 7Hoogerwerf WA. Biologic clocks and the gut [J], Curr Gastroenterol Rep, 2006, 8(5): 353-359.
  • 8Falcone A, Allegrini G, Antonuzzo A, et al. Infusion of fluorouracil and leucovorin effect of timing and semi-intermittency of drug delivery [J]. Oncology,1999,57 (3): 195-201.
  • 9Farker K,Merke IU,Wedding U, et al.Chronomodulated chemotherapy with oxaliplatin 5-Fu and sodium folinate in metastatic gastrointestinal cacer patients original analysis of non-hematological toxicity and patient characteristics in a pilot investigation [J]. Int J Clin Pharmacol Ther, 2006,44(1): 31-37.
  • 10Lis CG, Wood P, You M, et al. Circadian timing in cancer treatment:the biological foundation for an intergrative approach [ J ] .Integr Cancer Ther, 2003, 2(2): 105-111.

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部